ArticleAntibodies (Basel, Switzerland)2025
Developing a 3D Model Culture of an EBV+/CD30+ B-Anaplastic Large Cell Lymphoma Cell Line to Assay Brentuximab Vedotin Treatment.
Paolo Giannoni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.